These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 16402704

  • 1. [Optimizing therapy in Paget disease].
    Füessl HS.
    MMW Fortschr Med; 2005 Dec 15; 147(51-52):32. PubMed ID: 16402704
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.
    Pane A.
    Arch Ophthalmol; 2007 Oct 15; 125(10):1440-1. PubMed ID: 17923566
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug 15; 17(96):143. PubMed ID: 19480098
    [Abstract] [Full Text] [Related]

  • 8. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D, Martínez-Morillo M, Holgado S, Erra A.
    Med Clin (Barc); 2014 May 20; 142(10):469-70. PubMed ID: 24120108
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological therapy of Paget's and other metabolic bone diseases.
    Hosking D.
    Bone; 2006 Feb 20; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
    Labinson P, Taxel P.
    Conn Med; 2007 May 20; 71(5):269-73. PubMed ID: 17526382
    [No Abstract] [Full Text] [Related]

  • 12. Bilateral Ocular Pain and Hyperemia in a Patient With Paget Disease of the Bone.
    Haider AS, Burbidge AM, Dunlop A.
    JAMA Ophthalmol; 2017 Jun 01; 135(6):665-666. PubMed ID: 28358955
    [No Abstract] [Full Text] [Related]

  • 13. [Osteoporosis and bisphosphonates].
    Zuber MA.
    Z Rheumatol; 2007 Dec 01; 66(8):713-5. PubMed ID: 17955251
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paget disease of bone: therapeutic options.
    Silverman SL.
    J Clin Rheumatol; 2008 Oct 01; 14(5):299-305. PubMed ID: 18838910
    [Abstract] [Full Text] [Related]

  • 16. Paget's disease and bisphosphonates.
    Rendina D, De Filippo G, Mossetti G.
    N Engl J Med; 2005 Dec 15; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
    [No Abstract] [Full Text] [Related]

  • 17. Glucocorticoid-induced osteoporosis: hope on the HORIZON.
    Gennari L, Bilezikian JP.
    Lancet; 2009 Apr 11; 373(9671):1225-6. PubMed ID: 19362657
    [No Abstract] [Full Text] [Related]

  • 18. Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.
    Med Lett Drugs Ther; 2009 Jun 29; 51(1315):49. PubMed ID: 19556940
    [No Abstract] [Full Text] [Related]

  • 19. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
    Gueiros LA, Lopes MA, Leão JC.
    J Oral Maxillofac Surg; 2008 Jun 29; 66(6):1319. PubMed ID: 18486809
    [No Abstract] [Full Text] [Related]

  • 20. Bisphosphonate therapy and dental treatment.
    Phillips G.
    J Mich Dent Assoc; 2009 Aug 29; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.